NON HODGKIN LYMPHOMA (NHL)

Clinical trials for NON HODGKIN LYMPHOMA (NHL) explained in plain language.

Never miss a new study

Get alerted when new NON HODGKIN LYMPHOMA (NHL) trials appear

Sign up with your email to follow new studies for NON HODGKIN LYMPHOMA (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Cancer patients get chance to continue promising drug in Long-Term safety study

Disease control Completed

This study allowed patients with various cancers who had benefited from the drug tazemetostat in earlier trials to continue receiving it. The main goal was to monitor the drug's long-term safety in these patients. It was open to people who had not seen their cancer worsen and cou…

Matched conditions: NON HODGKIN LYMPHOMA (NHL)

Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

NON HODGKIN LYMPHOMA (NHL)

Get alerted when new NON HODGKIN LYMPHOMA (NHL) trials appear

Cancer patients get chance to continue promising drug in Long-Term safety study